Rockwell Medical (RMTI) Receivables (2010 - 2026)

Rockwell Medical has reported Receivables for 17 years, with the latest figure at $8.8 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 8.74% year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at $8.8 million (down 8.74% YoY), and the FY2025 full-year result was $8.1 million, down 1.79% from the prior year.
• Receivables for Q1 2026 stood at $8.8 million, up from $8.1 million in the prior quarter.
• The five-year high for Receivables was $16.2 million in Q2 2022, with the low at $5.4 million in Q2 2023.
• Historically, Receivables has averaged $9.7 million across 5 years, with a median of $8.9 million in 2024.
• Annual changes were most pronounced in 2023 — Receivables tumbled 66.56% — and 2024, when it surged 100.33%.
• Rockwell Medical's Receivables stood at $6.3 million in 2022, then jumped by 74.17% to $10.9 million in 2023, then declined by 23.94% to $8.3 million in 2024, then decreased by 1.79% to $8.1 million in 2025, then rose by 8.38% to $8.8 million in 2026.
• The last three Receivables figures came in at $8.8 million (Q1 2026), $8.1 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.